🇺🇸 FDA
Pipeline program

Investigational aQIVc

V201_03

Phase 3 mab completed

Quick answer

Investigational aQIVc for Influenza, Human is a Phase 3 program (mab) at Seqirus (Australia) Pty Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Seqirus (Australia) Pty Ltd
Indication
Influenza, Human
Phase
Phase 3
Modality
mab
Status
completed

Clinical trials